Network News Global

Where Every Story Matters

Warren Buffett Successor Greg Abel Made 3 Big Purchases Last Quarter, and They’re All Exceptional Performers
Business & Economy

Warren Buffett Successor Greg Abel Made 3 Big Purchases Last Quarter, and They’re All Exceptional Performers


Greg Abel has some big shoes to fill at Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB). As the new CEO, he’s in charge of the company’s massive portfolio of marketable equities. He’s also responsible for identifying new opportunities to acquire wholly owned subsidiaries for Berkshire and for creating strategic partnerships. Not to mention ensuring the current group of operating businesses stays on track.

Greg Abel probably won’t be able to replicate the success of Warren Buffett. Buffett himself would probably struggle to match his own track record. But Abel made three big moves at Berkshire in his first quarter, deploying billions in capital, and they’ve all been great successes so far.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »

Here are the three investments that set Abel off on the right foot as CEO.

The Berkshire Hathaway logo overlaid on an image of an office building.
Image source: Getty Images.

1. Oxychem

Berkshire Hathaway agreed to acquire Oxychem from Occidental Petroleum (NYSE: OXY) last October when Buffett was still CEO, but the deal didn’t close until January. Greg Abel was instrumental in negotiating the deal in which Berkshire paid Occidental $9.7 billion in cash for its chemicals business.

The deal was a success from the start. Abel and Buffett agreed to acquire the company when the chemical industry was near the bottom of an earnings cycle. It paid an estimated 8 times OxyChem’s 2025 EBITDA. That was roughly in line with other chemical stocks like Eastman Chemical and Dow at the time.

Both comparables have seen their valuation multiples expand in 2026 amid the ongoing conflict in Iran. With the Strait of Hormuz closed, international commodity supply chains have been disrupted, giving American chemical producers significant pricing power. OxyChem could also benefit from its planned modernization efforts for its facilities, improving cash flow and earnings on top of the pricing improvements.

Berkshire has very likely seen excellent operating results from OxyChem in its first quarter under the conglomerate’s umbrella. The cherry on top of the deal is that Berkshire was able to retain its preferred shares of Occidental Petroleum, continuing to receive an 8% dividend on about $8.3 billion.

2. Tokio Marine

Abel made a smart, successful investment while bolstering and expanding its core insurance business by striking a strategic investment in Tokio Marine (OTC: TKOMY). Berkshire paid $1.8 billion for a 2.5% stake in the Japanese insurer and received permission to increase its stake to 9.9% by buying shares on the open market. Additionally, the two agreed to a quota-share agreement under which Berkshire subsidiary National Indemnity absorbs some of Tokio Marine’s insurance risk. That could produce further upside to the investment, assuming good underwriting.



Source link

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *